Sectra ABCHIX:SECTBS 98 ROA % is 14.77% as of Apr. 2026, which is 3% below its 10-year median of 15.26. GuruFocus rates CHIX:SECTBS with a GF Score™ of 98/100 and a GF Value™ of kr307.25 (Modestly Undervalued). Among 857 Medical Devices & Instruments companies, Sectra AB ranks better than 93.82% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sectra AB's annualizedNet Income for the quarter that ended in Apr. 2026 was kr630 Mil.
Sectra AB's average Total Assets over the quarter that ended in Apr. 2026 was kr4,264 Mil. Therefore, Sectra AB's annualized ROA % for the quarter that ended in Apr. 2026 was 14.77%.
The historical rank and industry rank for Sectra AB's ROA % or its related term are showing as below:
CHIX:SECTBs'
s ROA % Range Over the Past 10 Years
Min: 13.16 Med: 15.26 Max: 17.42
Current: 14.42
During the past 13 years, Sectra AB's highest ROA % was 17.42%. The lowest was 13.16%. And the median was 15.26%.
CHIX:SECTBs's ROA % is ranked better than 93.82% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.56
vs CHIX:SECTBs: 14.42
Sectra AB (CHIX:SECTBs) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Apr. 2026) net income data. The Revenue data used here is four times the quarterly (Apr. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Sectra AB ROA % Related Terms
Sectra AB ROA % Historical Data
* Premium members only.
The historical data trend for Sectra AB's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sectra AB's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's ROA % distribution charts can be found below:
* The bar in red indicates where Sectra AB's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Apr. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Sectra AB (CHIX:SECTBS) has a ROA % of 14.77% as of Apr. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sectra AB and its competitors. This is near median its historical median of 15.26. Over the past decade, Sectra AB's ROA % has ranged from 13.16 to 17.42. According to the industry distribution chart, Sectra AB ranks #53 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 6.2%.
Is Sectra AB's ROA % too high?
Sectra AB's current ROA % of 14.77% is near median its 10-year median of 15.26. Over the past 10 years, this metric has ranged from a low of 13.16 to a high of 17.42. The Medical Devices & Instruments industry median ROA % is 0.56. Sectra AB's value of 14.77% is 2537.5% above this industry median. Based on the distribution chart, Sectra AB ranks #53 out of 857 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sectra AB has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #53 out of 857 companies for ROA %. This places Sectra AB in the top 6% of its industry — outperforming the majority of peers. The industry median ROA % is 0.56. Sectra AB's value of 14.77% is 2537.5% above this benchmark. Historically, Sectra AB's own ROA % has ranged from 13.16 to 17.42 over the past decade. While the company's 10-year median is 15.26 vs. the industry median of 0.56, Sectra AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current ROA % of 14.77% is 2537.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current ROA % is 14.77%, which is near median its own 10-year median of 15.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (CHIX:SECTBS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr307.25, compared to a current price of kr277.30 — trading 9.7% below its estimated fair value. The current ROA % is 14.77%, which is near median its 10-year median of 15.26 and 2537.5% above the Medical Devices & Instruments industry median of 0.56. Sectra AB's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Sectra AB (CHIX:SECTBS), the current ROA % is 14.77% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (CHIX:SECTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of kr277.30 is trading 9.7% below its estimated GF Value™ of kr307.25.
GuruFocus considers Sectra AB to be Modestly Undervalued.
Key valuation signals for CHIX:SECTBS:
ROA %: 14.77% (near median its 10-year median of 15.26)
GF Value™: kr307.25 vs. price of kr277.30 (9.7% below fair value)
Industry Position: 2537.5% above the Medical Devices & Instruments median (#53 of 857)
No single metric tells the full story. See the CHIX:SECTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
98GF Score
Get the complete analysis for CHIX:SECTBS
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SECTBS has been successfully added to your 
